Paul Campbell Appointment

Smith & Nephew Plc 01 October 2007 SMITH & NEPHEW ADVANCED WOUND MANAGEMENT APPOINTS PAUL CAMPBELL AS VICE PRESIDENT OF STRATEGIC MARKETING Hull, ENG. and Largo, FL, October 1, 2007 -Smith & Nephew's (LSE: SN; NYSE:SNN) Advanced Wound Management division today announced the appointment of Paul Campbell as Vice President of Strategic Marketing for its Advanced Wound Care Strategic Business Unit (SBU). Campbell joins Smith & Nephew from J&J Medical, where he commenced his career in regional Territory Management and Marketing Management roles for ETHICON Sutures followed by a Product Director role, a Franchise Manager role, European Business Manager for Haemostasis products and latterly as Group Marketing Director Worldwide for Surgical Meshes. These roles spanned various geographies, and he has lived and worked in France, Israel, Turkey, the US as well as the UK. 'Paul has worked in the medical device industry for the last 18 years with particular focus in Sales and Marketing. In that time he has gained a broad range of international experience and has demonstrated success in a number of senior management positions', commented Roger Teasdale Senior Vice President. In this role Campbell will report to Roger Teasdale, Senior Vice President of the Advanced Wound Care SBU. Campbell holds a Masters in Languages and an MBA from the University of Edinburgh. FOR IMMEDIATE RELEASE Contact: Sidonie Myers Smith & Nephew Advanced Wound Management + 44 1482 673246 About Smith & Nephew: Smith & Nephew is a global medical technology business, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company has 9,600 employees and operates in 31 countries around the world. Annual sales in 2006 were nearly $2.8 billion. ### This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings